Key risk factors include: Pre-existing liver disease patients with chronic hepatitis, cirrhosis, or existing NAFLD are at increased risk Obesity and metabolic syndrome body mass index (BMI) over 30 kg/m, central adiposity, and insulin resistance Type 2 diabetes mellitus impaired glucose metabolism significantly raises NAFLD risk Polypharmacy concurrent use of other medications
But randomized controlled trials of these molecules, which suppress inflammation throughout the body, were abandoned because they showed no clear benefit
A+BBB Rating 4.9 StarGoogle Reviews A+BBB Rating 4.9 StarGoogle Reviews Ozempic Lawsuit Process Expert Verified Our content is developed and backed by respected legal, medical and scientific experts
What is the difference between medical infusion and IV hydration therapy
This study highlights that: Delayed gastric emptying is clinically significant Standard fasting guidelines may be insufficient Gastric ultrasound is a valuable tool for risk stratification As GLP-1 use continues to expand, anesthesiologists must adapt their practices to ensure patient safety